Lasca

Ethinylestradiol and Levonorgestrel, the active ingredient in Lasca, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. It works to prevent pregnancy in women of reproductive age by inhibiting ovulation and creating cervical mucus changes that reduce sperm penetration.

GNH USA supplies Lasca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions.

Lasca, a combined estrogen‑progestogen oral contraceptive, is used in hormonal contraception and related menstrual disorders. - Contraception (prevention of pregnancy): provides reliable hormonal birth control for women of childbearing age. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces menstrual discomfort. - Acne improvement: decreases androgen‑driven skin lesions, leading to clearer complexion in some users.

Like all hormonal contraceptives, Lasca may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Breast tenderness: swelling or discomfort in the breasts. - Headache: mild to moderate intensity. - Spotting or breakthrough bleeding: irregular light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins, requiring immediate medical attention. - Pulmonary embolism: clot migration to lungs, a life‑threatening emergency. - Stroke: rare cerebrovascular event associated with hormonal therapy. - Severe allergic reaction: rash, swelling, or difficulty breathing.

Before prescribing Lasca, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiovascular risk: avoid in women with history of thromboembolic disorders or uncontrolled hypertension. - Evaluate liver function: contraindicated in severe hepatic impairment. - Review smoking status: do not use in smokers over 35 years of age. - Counsel on medication adherence: missing tablets can reduce effectiveness. - Discuss potential drug interactions: inform about concomitant use of enzyme‑inducing agents. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Lasca can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive effectiveness. - Antifungal azoles (e.g., ketoconazole): can increase hormone levels, raising risk of side effects. - Certain antiretrovirals (e.g., efavirenz): may lower plasma concentrations, compromising contraception.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., sertraline): may slightly increase bleeding tendency. - Anticonvulsants with moderate enzyme induction (e.g., phenytoin): require monitoring of cycle control. - Herbal supplements (e.g., St. John’s wort): may modestly decrease hormonal levels.